Xeris Biopharma appoints Menassie M. Taddese to board of directors
XERS•Xeris Biopharma appointed Menassie M. Taddese to its board, effective November 2, 2026. He will also serve on the Audit Committee.
1. Board appointment
Taddese most recently served as president of emerging markets at Viatris and has more than 20 years of experience at Pfizer.
